Clinical outcomes and safety of colistin in treatment of gram negative infections: A prospective observational study

Background: Despite the fact that colistin has a significant activity against MDR gram-negative organisms, its toxicity limits its use. However, the limited therapeutic options due to increasing antibiotic resistance have made re-evaluation of older antibiotics inevitable. In contrast, lack of data...

Full description

Bibliographic Details
Main Authors: Kinnari Desai, Mubin Kazi, Kanchan Ajbani, Mohseen Munshi, Camilla Rodrigues, Rajeev Soman, Anjali Shetty
Format: Article
Language:English
Published: Wolters Kluwer 2016-08-01
Series:Egyptian Journal of Critical Care Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2090730316300275